Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep vs Standard NMB in Robotic Radical Prostatectomy
NCT02513693Phase 4Unknown
- Sponsor
- Palacky University Olomouc
- Start
- Jul 2015
- Primary completion
- Mar 2016
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Palacky University Olomouc. Primary endpoint: Surgical condition. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02513693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02513693.